Theralase Technologies Inc. designs, develops, manufactures and markets patented, superpulsed laser technology utilized in biostimulation and biodestruction applications. The technology is safe and effective in the treatment of chronic pain, neural muscular-skeletal conditions and wound care. When combined with its patented, light-sensitive Photo Dynamic Compounds, Theralase laser technology is able to specifically target and destroy cancers, bacteria, viruses as well as microbial pathogens.
Friday, April 12, 2013
TSX Venture Exchange Has Consented to the Extension of Warrants
THERALASE TECHNOLOGIES INC. ("TLT") BULLETIN TYPE: Warrant Term Extension BULLETIN DATE: April 11, 2013 TSX Venture Tier 2 Company
TSX Venture Exchange has consented to the extension in the expiry date of the following warrants:
# of Warrants: Original Expiry Date of Warrants: New Expiry Date of Warrants: Exercise Price of Warrants:
1,500,000 April 13, 2013 April 13, 2017 $0.38
These warrants were issued pursuant to a private placement of 3,000,000 shares with 1,500,000 share purchase warrants attached, which was accepted for filing by the Exchange effective April 16, 2012.
For further information please call 1-866-843-5273 or visit www.theralase.com